Showing posts with label Channel News Asia. Show all posts
Showing posts with label Channel News Asia. Show all posts

Saturday 2 January 2021

How the pandemic will change travel in 2021, from vaccinations to global nomadism

‘Travel has been changed by past calamities. Safety measures instituted after the 9/11 attacks are now just part of the travel experience. It’s unclear just which changes to the travel landscape will be in place a year from now – or 10 years on – but some answers are starting to come into focus.

‘On the brink of the new year, we looked at nine of the most pressing queries facing the travel industry and individual travellers...’

Read here (Channel News Asia, Jan 2, 2021)

Thursday 24 December 2020

Fauci says herd immunity could require ‘between 70% and 90%’ to get COVID-19 vaccine

‘Herd immunity against the novel coronavirus could require vaccination rates "between 70 per cent and 90 per cent", Dr Anthony Fauci, the most prominent US infectious disease expert, said in an interview published on Thursday (Dec 24). More than 1 million Americans have received a first dose of a vaccine since Dec 14, according to the US Centers for Disease Control, or only about 0.3 per cent of the population.

‘Fauci, who is advising both President Donald Trump and President-elect Joe Biden on the pandemic, acknowledged that he had incrementally increased his estimates from earlier in the year, when he tended to say only 60 per cent to 70 per cent would need to be inoculated for herd immunity to be reached.’

Read here (Channel News Asia, Dec 25, 2020)

Tuesday 15 December 2020

Teachers should receive COVID-19 vaccine priority: UNICEF

‘The head of the UN children's agency, UNICEF, called on Tuesday (Dec 15) for teachers to be among those given priority access to the COVID-19 vaccines. "The COVID-19 pandemic has wreaked havoc on children's education around the globe. Vaccinating teachers is a critical step towards putting it back on track," UNICEF chief Henrietta Fore said in a statement. Teachers should be "prioritised to receive the COVID-19 vaccine, once frontline health personnel and high-risk populations are vaccinated," she said.’

Read here (Channel News Asia, Dec 15, 2020)

Saturday 12 December 2020

Covid-19 vaccine is permissible for Muslim use, preservation of life is key consideration: MUIS

‘The Islamic Religious Council of Singapore (MUIS) said on Sunday (Dec 13) that it "holds the position that a COVID-19 vaccine is permissible for Muslim use". "We would advise and encourage Muslims to be vaccinated once it is available and when the vaccine has been medically authorised as safe and effective, as this is a basic necessity to protect lives in the context of a global pandemic," said MUIS.’

Read here (Channel News Asia, Dec 13, 2020)

WHO to make decisions on Pfizer, Moderna, AstraZeneca COVID-19 vaccines in weeks

‘The World Health Organization expects to make decisions on whether to give emergency use approval to COVID-19 vaccines from Pfizer, Moderna and AstraZeneca in the coming weeks, its chief scientist said on Friday (Dec 11).

‘Soumya Swaminathan said the global health body could decide on Pfizer's vaccine candidate in the next "couple of weeks", and later said it could also review Moderna's and AstraZeneca's candidates in a few weeks.’

Read here (Channel News Asia, Dec 12, 2020)

Wednesday 9 December 2020

Rich countries have bought too many Covid-19 vaccines: Amnesty International

‘Rich countries have secured enough coronavirus vaccines to protect their populations nearly three times over by the end of 2021, Amnesty International and other groups said on Wednesday (Dec 9), possibly depriving billions of people in poorer areas. "Nearly 70 poor countries will only be able to vaccinate one in 10 people against COVID-19 next year unless urgent action is taken," Amnesty International said, based on recent calculations. "Updated data shows that rich nations representing just 14 per cent of the world's population have bought up 53 per cent of all the most promising vaccines so far," it said.’  

Read here (Channel News Asia, Dec 9, 2020)

Thursday 26 November 2020

AstraZeneca says its Covid-19 vaccine needs 'additional study'

‘The head of British drug manufacturer AstraZeneca said on Thursday (Nov 26) further research was needed on its COVID-19 vaccine after questions emerged over the protection it offers, but the additional testing is unlikely to affect regulatory approval in Europe.

‘Instead of adding the trial to an ongoing US process, AstraZeneca might launch a fresh study to evaluate a lower dosage of its vaccine that performed better than a full dosage, AstraZeneca chief executive Pascal Soriot was quoted as saying in a Bloomberg News report.’

Read here (Channel News Asia, Nov 27, 2020)

Wednesday 25 November 2020

Businesses and residents near Top Glove dormitories on edge, as Covid-19 cases spike among workers

"We didn't know about workers being infected until last week," said resident Kandasamy Padakat Hurian, 43 who lives in a house directly across a worker dormitory. "When I went out to work at 7am on Monday (Nov 16), army trucks and the police were already here. By evening when I returned, the (barbed) wire was in place," Mr Kandasamy recounted. Prior to last week, Jalan Teratai would be busy in the evenings as petty traders and hawkers lined the road with stalls. "When the government came and locked down the place, everyone fled. It has become very quiet,” he said 

Read here (Channel News Asia, Nov 26, 2020)

Monday 23 November 2020

A larger, more sinister pandemic lurks beneath Covid-19

‘More than one in five Americans hospitalised with COVID-19 also contracts a bacterial infection. Absent effective antibiotics, those lucky enough to beat the coronavirus might die at the hands of these not-so-novel pathogens. 

‘Unfortunately, the pipeline of new antibiotics is running dry. Less than 100 years after the development of penicillin, drug-resistant superbugs are threatening to gain the upper hand in our fight against bacterial infections.Superbugs already take an enormous toll on health-care systems around the world. About 700,000 people globally die each year due to antimicrobial resistance (AMR). Without new and better treatments, that figure could rise to ten million by 2050.’

Read here (Channel News Asia, Nov 23, 2020)

Thursday 19 November 2020

WHO advises against remdesivir for COVID-19 treatment

‘The anti-viral drug remdesivir should not be used to treat COVID-19 patients no matter how severe their illness as it has "no important effect" on survival chances, the World Health Organization said on Friday (Nov 20).

‘Scratching one of the few treatments that had shown some initial promise in severe patients, a WHO Guideline Development Group (GDG) of international experts said there was "no evidence based on currently available data that it does improve patient-important outcomes".’

Read here (Channel News Asia, Nov 20, 2020) 

Tuesday 10 November 2020

How Pfizer Covid-19 vaccine could be cold comfort for some Asian nations

‘With tropical heat, remote island communities and a dearth of ultra-cold freezers, many Asian countries aren't betting on Pfizer's experimental vaccine solving their COVID-19 crisis any time soon. The world cheered on Monday (Nov 9) when Pfizer announced its shot, jointly developed with BioNTech SE, was more than 90 per cent effective based on initial trial results. Yet health experts cautioned that the vaccine, should it be approved, was no silver bullet - not least because the genetic material it's made from needs to be stored at temperatures of minus 70 degrees Celsius or below.’

Read here (Channel News Asia, Nov 10, 2020) 

Sunday 25 October 2020

More mass testing in China after 137 Covid-19 cases in Xinjiang: All new cases asymptomatic

‘Mass testing began on Saturday evening to cover 4.75 million residents in and around Kashgar, Xinjiang province, after a 17-year-old garment factory worker tested positive for the virus. The new cases - all asymptomatic - were linked to a factory in Shufu county where the girl and her parents worked, the Xinjiang health commission told a press briefing on Sunday.’

Read here (Channel News Asia, Oct 26, 2020)

Monday 19 October 2020

NUS start-up develops 60-second breath test to detect Covid-19

‘Researchers in Singapore have developed a breath test to detect COVID-19 within a minute, said the National University of Singapore (NUS) on Tuesday (Oct 20). The test, which detects volatile organic compounds (VOC) in a person’s breath, achieved more than 90 per cent accuracy in a clinical trial involving 180 patients.’ 

Read here (Channel News Asia, Oct 20, 2020)

Saturday 17 October 2020

‘No longer groping in the dark’: NCID doctors share how Covid-19 is being treated in Singapore

‘So far, 28 people have died of COVID-19 in Singapore - one of the lowest mortality rates in the world. In the US, where there have been about 8 million cases, more than 200,000 people have died. As of Saturday (Oct 17), 37 COVID-19 patients remain hospitalised in Singapore, with none in intensive care. More than 99 per cent of those infected have been discharged, while there are 41 in community care facilities.

‘But it wasn't always like this. Three National Centre for Infectious Diseases (NCID) consultants told CNA how treatment of the novel coronavirus has evolved here and how NCID has kept the number of critical cases low.’

Read here (Channel News Asia, Oct 18, 2020)

Friday 16 October 2020

When will Covid-19 end? History suggests diseases fade but are never truly gone

‘Whether bacterial, viral or parasitic, virtually every disease pathogen that has affected people over the last several thousand years is still with us, because it is nearly impossible to fully eradicate them. The only disease that has been eradicated through vaccination is smallpox. Mass vaccination campaigns led by the World Health Organization in the 1960s and 1970s were successful, and in 1980, smallpox was declared the first – and still, the only – human disease to be fully eradicated. So success stories like smallpox are exceptional. It is rather the rule that diseases come to stay.’

Read here (Channel News Asia, Oct 17, 2020)

Tuesday 6 October 2020

White House contact tracing questioned as Covid-19 spreads in Washington

‘The White House contact tracing programme is too haphazard to pinpoint or halt a COVID-19 outbreak that was rapidly spreading in the US capital city, health experts and city officials said on Tuesday (Oct 6). Washington reported 105 new cases of the coronavirus for Oct 5, the mayor's office said, the highest figure since June...

‘A White House event on Sep 26 for Supreme Court nominee Amy Coney Barrett was suspected of spreading infections, as was an Air Force One flight that evening with Trump. But several staff members, guests and journalists at the event or on the flight told Reuters they have not been contacted by the White House medical team.’

Read here (Channel News Asia, Oct 7, 2020)

Wednesday 16 September 2020

Rich nations have cornered half of future COVID-19 vaccine supply: Oxfam

‘A group of wealthy nations representing 13 per cent of the global population have already bought up more than half of the promised doses of future COVID-19 vaccines, according to a report by Oxfam on Wednesday (Sep 16).

‘The non-governmental organisation analysed deals struck by pharmaceuticals and vaccine producers for the five leading vaccine candidates currently in late-stage trials, based on data collected by the analytics company Airfinity.’

Read here (Channel News Asia, Sept 17, 2020)

Sunday 13 September 2020

India considers emergency authorisation of vaccine as COVID-19 cases surge

‘India said on Sunday (Sep 13) it was considering granting an emergency authorisation for a COVID-19 vaccine, particularly for the elderly and people in high-risk workplaces, as the country's number of reported infections passed 4.75 million. India, which has consistently reported over 1,000 COVID-19 deaths daily this month, has now recorded 78,586 fatalities from the disease. It lags only the United States globally in overall number of infections, but it has been adding more daily cases than the United States since mid-August. "India is considering emergency authorisation of a COVID-19 vaccination," said Health Minister Harsh Vardhan. "If there is a consensus we may go ahead with it, especially in the case of senior citizens and people working in high-risk settings."

Read here (Channel News Asia, Sept 14, 2020)

Monday 7 September 2020

Skills lost due to COVID-19 school closures will hit output for generations: OECD

‘Disruption to schooling stemming from the COVID-19 epidemic will cause a skill loss that could result in a 1.5 per cent drop in global economic output for the rest of this century, the Organisation for Economic Cooperation and Development estimated.

‘For the United States, that will represent an economic loss of US$15.3 trillion, the OECD said in a report published on Tuesday (Sep 8), with the bill rising higher still if disruption to education extends into the next academic year.’ 

Read here (Channel News Asia, Sept 8, 2020)

Sunday 6 September 2020

World’s struggle with coronavirus will affect growth and employment for a long time

‘The next few months will tell us a lot about the shape of the coming global recovery. Despite ebullient stock markets, uncertainty about COVID-19 remains pervasive. Regardless of the pandemic’s course, therefore, the world’s struggle with the virus so far is likely to affect growth, employment, and politics for a very long time.’

Read here (Channel News Asia, Sept 7, 2020)

Worst ever Covid variant? Omicron

John Campbell shares his findings on Omicron.  View here (Youtube, Nov 27, 2021)